Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter 2011
Date:11/7/2011

t also on the longer-term commercial opportunities as we continue to develop this important product," continued Ms. Parshall.

"Although Kynamro is our flagship drug and will be the first systemic antisense drug to reach the market, our pipeline goes well beyond Kynamro.  Numerous drugs in our pipeline have demonstrated efficacy in early clinical studies and could represent significant commercial opportunities," continued Ms. Parshall. "The success of our drug discovery and development efforts is evident every quarter as we move our drugs closer to the market.  Already this year, we have initiated clinical studies on five drugs, reported encouraging data on our CRP drug and added new drugs into development to treat a wide variety of diseases.   We anticipate continuing this steady progress for the rest of the year and into 2012.

"Our business strategy is successful as evidenced by the growth of our partnered pipeline and the substantial cash from our partnering deals.  We benefit financially both in the near-term and long-term, from upfront fees, milestone payments, royalties and profit sharing payments and other types of commercial participation.  This year, we have earned $13 million in milestones and upfront payments from our partner, GSK, with the expansion of our collaboration to include a sixth target, initiation of clinical development on our TTR drug and identification of the next drug, ISIS-AATRx, to move into development.  This collaboration provides us with a knowledgeable partner and allows us to quickly expand our severe and rare disease franchise," concluded Ms. Parshall.  

Corporate and Drug Development Highlights

  • Dr. John Kastelein presented data from the mipomersen open-label extension study at the European Society of Cardiology Congress 2011.  These data, in patients who have been treated with mipomersen for greater than one year, demonstrated sustained reductions in
    '/>"/>

  • SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
    2. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    3. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
    4. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
    5. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
    6. Cambrex Reports Third Quarter 2011 Results
    7. Dyadic International Reports 2011 Third Quarter Financial Results
    8. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
    9. Mettler-Toledo International Inc. Reports Third Quarter 2011 Results
    10. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
    11. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... -- On Thursday, July 10, 2014, ... Jones Industrial Average finished the day 0.42% lower at 16,915.07, ... losses were broad based as eight out of ten sectors ... Sector Index ended the day at 711.88, down 0.02%, while ... Investor-Edge has initiated coverage on the following equities: Covidien PLC ...
    (Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
    (Date:7/10/2014)... MUMBAI, India , July 11, 2014 /PRNewswire/ ... the treatment of cancer are being highlighted in ... Mumbai from 10-12 July, 2014.  Renowned ... meeting to share best practices and exchange knowledge ... more precise, accurate and efficient. ...
    Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Veran Medical Publishes Lung Cancer Patient Management Study 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
    ... Aug. 22, 2011 Reportlinker.com announces ... is available in its catalogue: ... Strategic Assessments of Leading Suppliers ... This report provides diagnostic imaging ...
    ... Santosh Nanda, Microbiologist/ Primary Reviewer, CBER, FDA ... have announced their official participation at the Viral ... the 17th October to 19th October 2011 in NH ... has expanded its focus from solely viral safety to ...
    Cached Medicine Technology:Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 2Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 3Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 4Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 5Food and Drug Administration (FDA) Joins Pharma IQ's Viral Safety 2011 Conference 2
    (Date:7/12/2014)... Pittsburgh, PA (PRWEB) July 12, 2014 ... embarrassing, so one of two inventors from Ashland, Va., ... to do this. "This inspired us to conceive of ... prototype of the patent-pending KIDNEY KOVER, which provides an ... bag. It avoids embarrassment, as well as promotes comfort ...
    (Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, ... to showcase its new and trendy apparels. Recently, the ... in its online shop. Additionally, it is now providing ... gowns. According to the company’s sales manager, the promotion ... , He says, “Now, worldwide clients can order ...
    (Date:7/12/2014)... 2014 Wright & Schulte LLC has filed ... Inc., a subsidiary of Johnson & Johnson, on behalf of ... after receiving a metal-on-metal DePuy Pinnacle hip replacement and had ... artificial hip implant. The DePuy hip lawsuit was filed July ... Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit ...
    (Date:7/12/2014)... Warminster, PA (PRWEB) July 12, 2014 ... Paddock covering a variety of men’s health questions. ... issues specific to men, why women live longer than ... article, Men's Health Made Simple featured on ... can get a hernia at any age. If you ...
    (Date:7/12/2014)... 12, 2014 Utah Valley Entrepreneurial Forum ... with awards being bestowed to companies in revenue, and ... entrepreneur community with recognition for new ideas as well ... incoming revenue. , 25 Under 5 highlights outstanding Utah ... are under 5 years old. Award recipients were recognized ...
    Breaking Medicine News(10 mins):Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
    ... findings of a study carried out at Hammersmith hospital reveal ... as effective at protecting women from developing cervical abnormalities as ... Professor Jack Cuzick of Barts and The London School of ... 2008) in the International Journal of Cancer. , Nearly 3,000 ...
    ... NEW YORK, May 14 The F.A.C.E. ... help connect and empower African-Americans,to take a ... report from Eli Lilly and Company at:, ... video, audio, text, graphics and,photos for free ...
    ... Cancellation Lawsuits Contributed,$804,600 to Governor, SANTA MONICA, Calif., ... industry insiders the state,s top HMO,regulator is considering a ... paying for past medical bills for some patients whose ... is also rumored to include,provisions designed to limit Kaiser,s ...
    ... Danny Diaz released the following statement today:, "Barack ... by Congress raises serious doubts about his understanding of,what ... actually is. His refusal,to enforce the law reveals that ... job of President, or that he fundamentally lacks the,judgment ...
    ... 15th issue of G&D, Dr. Guillermina Lozano (MD Anderson Cancer ... form of p53 affects oncogenesis, and lends startling new insight ... therapy. , "Our data are both exciting and sobering: we ... to treatment, emphasizes Dr. Lozano. , One function of the ...
    ... Inc.,(NYSE: NUS ) today announced the board of ... which will be paid on June 18, 2008, to,stockholders ... Nu Skin Enterprises, Inc. is a global direct ... and Europe. The company markets,premium quality personal care products ...
    Cached Medicine News:Health News:Research shows HPV testing offers women protection for twice as long as smear testing 2Health News:Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 2Health News:RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS 2
    ... The Double Aspheric 78D is an ... lens offering an ideal .93x image ... of view. It is optimally designed ... motion of all slit lamps. Available ...
    The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
    The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
    ... Automated Urine Microscopy Analyzer (iQ200) uses ... software to classify urine particles into ... The iQ200 eliminates most technologist time ... images by automating specimen preparation, image ...
    Medicine Products: